If you or your spouse has diabetes, what are the chances your children will also develop the disease? Dr. David Greene (who lives with type 1) did the research, and some of it may surprise you.
read more →
SGLT-2 Inhibitors including Invokana (canagliflozin), Farxiga (dapagliflozin), Jardiance (empagliflozin) and Steglatro (ertugliflizin), are the newest class of oral medications for the treatment of type 2 diabetes. They’re generally well tolerated and associated with significant weight loss compared with other type 2 oral meds, but there are still precautions to consider.
read more →
Diabetes Clinician Nalani Haviland, who also has lived with type 1 diabetes for over 2o years, shares her recent experience with the implantable Eversense CGM.
read more →
The use of DPP-4 inhibitors (Januvia, Onglyza, Tradjenta and Nesina) has been so widespread because these medications come in a pill, only need to be taken once a day and have few side effects.
read more →
The A1c test has been around for a long time and is supposed to give people an idea of what their average glucose value has been over the prior two to three months, but there are many situations where the A1c is not accurate.
read more →
